James O. Hill, Ph.D., and Holly Wyatt, M.D., researchers specializing in weight loss maintenance, explain the reasons why ...

Novo Nordisk will cut prices for Ozempic and Wegovy by up to 50% next year, prompting employers to plan for rising use and ...

For restaurants and food companies, the increasing adoption of GLP-1 drugs present both an opportunity and a threat to their ...

The prevalence of GLP-1 prescriptions increased dramatically from 0.22% in quarter 4 of 2018 to 24.17% in quarter 3 of 2025, representing more than a 100-fold increase over the study period. Metabolic ...

XL men’s store sees sales fall by 6% as Americans turn to weight-loss drugs - The CEO of DXL said of GLP-1 drugs, ‘We didn't ...

Meals and snacks with “GLP-1 Friendly” labels on the packaging are becoming more common in U.S. supermarkets as a growing number of Americans try obesity drugs such as Wegovy and Zepbound to lose ...

The GLP-1 revolution shows no signs of slowing down. A pill version of the appetite-suppressing drug, Wegovy, hit the shelves of 70,000 U.S. pharmacies in January 2026. In the same month, UK-based ...

Meals and snacks with “GLP-1 Friendly” labels on the packaging are becoming more common in U.S. supermarkets as a growing number of Americans try obesity drugs like Wegovy and Zepbound to lose weight.

GLP-1 usage is on the rise, and researchers are looking for other health benefits associated with the drug, including its effects on bladder health. But as GLP-1s rise in popularity, so do nicknames ...